Tower Research Capital LLC (Trc) 9 Meters Biopharma, Inc. Transaction History

Tower Research Capital LLC (Trc)

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$0.21 - $0.32 $6,348 - $9,673	30,229 New	30,229 $6,000
Q2 2022 Aug 15, 2022	SELL	$0.26 - $0.64 $3,982 - $9,804	-15,319 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$0.52 - $1.0 $1,639 - $3,152	3,152 Added 25.91%	15,319 $9,000
Q4 2021 Feb 14, 2022	SELL	$0.85 - $1.33 $1,215 - $1,901	-1,430 Reduced 10.52%	12,167 $12,000
Q3 2021 Nov 15, 2021	SELL	$1.03 - $1.41 $9,087 - $12,440	-8,823 Reduced 39.35%	13,597 $17,000
Q2 2021 Aug 16, 2021	BUY	$1.04 - $1.5 $16,385 - $23,632	15,755 Added 236.38%	22,420 $25,000
Q1 2021 May 17, 2021	BUY	$0.84 - $2.16 $5,598 - $14,396	6,665 New	6,665 $8,000
Q3 2020 Nov 16, 2020	SELL	$0.48 - $0.84 $90,533 - $158,434	-188,612 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$0.43 - $0.74 $81,103 - $139,572	188,612 New	188,612 $108,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.